Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1987 May; 80(5): 274–278.
PMCID: PMC1290806

Drug abuse and human immunodeficiency virus infection in Scotland.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Acheson ED. AIDS: a challenge for the public health. Lancet. 1986 Mar 22;1(8482):662–666. [PubMed]
  • Ludlam CA, Tucker J, Steel CM, Tedder RS, Cheingsong-Popov R, Weiss RA, McClelland DB, Philp I, Prescott RJ. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet. 1985 Aug 3;2(8449):233–236. [PubMed]
  • Peutherer JF, Edmond E, Simmonds P, Dickson JD, Bath GE. HTLV-III antibody in Edinburgh drug addicts. Lancet. 1985 Nov 16;2(8464):1129–1130. [PubMed]
  • O'Dowd TC, Pill R, Smail JE, Davis RH. Irritable urethral syndrome: follow up study in general practice. Br Med J (Clin Res Ed) 1986 Jan 4;292(6512):30–32. [PMC free article] [PubMed]
  • Brettle RP, Davidson J, Davidson SJ, Gray JM, Inglis JM, Conn JS, Bath GE, Gillon J, McClelland DB. HTLV-III antibodies in an Edinburgh clinic. Lancet. 1986 May 10;1(8489):1099–1099. [PubMed]
  • Franceschi S, Tirelli U, Vaccher E, Serraino D, Sorio R, Carbone A, Monfardini S. Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military base. Lancet. 1986 Apr 5;1(8484):804–804. [PubMed]
  • Spira TJ, Des Jarlais DC, Marmor M, Yancovitz S, Friedman S, Garber J, Cohen H, Cabradilla C, Kalyanaraman VC. Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. N Engl J Med. 1984 Aug 16;311(7):467–468. [PubMed]
  • Levy N, Carlson JR, Hinrichs S, Lerche N, Schenker M, Gardner MB. The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl J Med. 1986 Feb 13;314(7):446–446. [PubMed]
  • Mortimer PP, Vandervelde EM, Jesson WJ, Pereira MS, Burkhardt F. HTLV-III antibody in Swiss and English intravenous drug abusers. Lancet. 1985 Aug 24;2(8452):449–450. [PubMed]
  • Fuchs D, Blecha HG, Deinhardt F, Dierich MP, Goebel FD, Hengster P, Hinterhuber H, Schoenitzer D, Traill K, Wachter H. High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol. Lancet. 1985 Jun 29;1(8444):1506–1506. [PubMed]
  • Ferroni P, Geroldi D, Galli C, Zanetti AR, Cargnel A. HTLV-III antibody among Italian drug addicts. Lancet. 1985 Jul 6;2(8445):52–53. [PubMed]
  • Aiuti F, Rossi P, Sirianni MC, Carbonari M, Popovic M, Sarngadharan MG, Contu L, Moroni M, Romagnani S, Gallo RC. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Br Med J (Clin Res Ed) 1985 Jul 20;291(6489):165–166. [PMC free article] [PubMed]
  • Angarano G, Pastore G, Monno L, Santantonio T, Luchena N, Schiraldi O. Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet. 1985 Dec 7;2(8467):1302–1302. [PubMed]
  • Robertson JR, Bucknall AB, Wiggins P. Regional variations in HIV antibody seropositivity in British intravenous drug users. Lancet. 1986 Jun 21;1(8495):1435–1436. [PubMed]
  • Brettle RP. Epidemic of AIDS related virus infection among intravenous drug abusers. Br Med J (Clin Res Ed) 1986 Jun 21;292(6536):1671–1671. [PMC free article] [PubMed]
  • Redfield RR, Markham PD, Salahuddin SZ, Wright DC, Sarngadharan MG, Gallo RC. Heterosexually acquired HTLV-III/LAV disease (AIDS-related complex and AIDS). Epidemiologic evidence for female-to-male transmission. JAMA. 1985 Oct 18;254(15):2094–2096. [PubMed]
  • Stewart GJ, Tyler JP, Cunningham AL, Barr JA, Driscoll GL, Gold J, Lamont BJ. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet. 1985 Sep 14;2(8455):581–585. [PubMed]
  • Kreiss JK, Kitchen LW, Prince HE, Kasper CK, Essex M. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission. Ann Intern Med. 1985 May;102(5):623–626. [PubMed]
  • Burger H, Weiser B, Robinson WS, Lifson J, Engleman E, Rouzioux C, Brun-Vézinet F, Barré-Sinoussi F, Montagnier L, Chermann JC. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Am J Med. 1986 Jul;81(1):5–10. [PubMed]
  • Friedland GH, Saltzman BR, Rogers MF, Kahl PA, Lesser ML, Mayers MM, Klein RS. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med. 1986 Feb 6;314(6):344–349. [PubMed]
  • Christenson B. Epidemiological aspects of the transmission of hepatitis B by HBsAg-positive adopted children. Scand J Infect Dis. 1986;18(2):105–109. [PubMed]
  • McGowan A, Steedman D, Schofield TC, Robertson CE. Parenteral drug misuse and the accident and emergency department. Health Bull (Edinb) 1984 Sep;42(5):252–257. [PubMed]
  • Scott GB, Fischl MA, Klimas N, Fletcher MA, Dickinson GM, Levine RS, Parks WP. Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA. 1985 Jan 18;253(3):363–366. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press